Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Lindberg

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Journal of Neurology|August 9, 2011
A retrospective clinical study of the treatment of slow-channel congenital myasthenic syndromeAmina Chaouch, Juliane S Müller, Velina Guergueltcheva, et al.
JAMA Neurology|September 19, 2022
Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis: The RINOMAX Randomized Clinical TrialFredrik Piehl, Ann Eriksson-Dufva, Anna Budzianowska, et al.
European Journal of Neurology|November 6, 2025
Rituximab in New-Onset Generalized Myasthenia Gravis: Long-Term Follow-Up of the RINOMAX Clinical TrialJing Wu, Ann Eriksson-Dufva, Anna Budzianowska, et al.
Brain : a Journal of Neurology|August 12, 2020
Loss of supervillin causes myopathy with myofibrillar disorganization and autophagic vacuolesCarola Hedberg-Oldfors, Robert Meyer, Kay Nolte, et al.
Orphanet Journal of Rare Diseases|August 17, 2019
Correction to: Eight years after an international workshop on myotonic dystrophy patient registries: case study of a global collaboration for a rare diseaseLibby Wood, Guillaume Bassez, Corinne Bleyenheuft, et al.
Orphanet Journal of Rare Diseases|September 7, 2018
Eight years after an international workshop on myotonic dystrophy patient registries: case study of a global collaboration for a rare diseaseLibby Wood, Guillaume Bassez, Corinne Bleyenheuft, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Journal of Neurology|August 9, 2011
A retrospective clinical study of the treatment of slow-channel congenital myasthenic syndromeAmina Chaouch, Juliane S Müller, Velina Guergueltcheva, et al.
JAMA Neurology|September 19, 2022
Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis: The RINOMAX Randomized Clinical TrialFredrik Piehl, Ann Eriksson-Dufva, Anna Budzianowska, et al.
European Journal of Neurology|November 6, 2025
Rituximab in New-Onset Generalized Myasthenia Gravis: Long-Term Follow-Up of the RINOMAX Clinical TrialJing Wu, Ann Eriksson-Dufva, Anna Budzianowska, et al.
Brain : a Journal of Neurology|August 12, 2020
Loss of supervillin causes myopathy with myofibrillar disorganization and autophagic vacuolesCarola Hedberg-Oldfors, Robert Meyer, Kay Nolte, et al.
Orphanet Journal of Rare Diseases|August 17, 2019
Correction to: Eight years after an international workshop on myotonic dystrophy patient registries: case study of a global collaboration for a rare diseaseLibby Wood, Guillaume Bassez, Corinne Bleyenheuft, et al.
Orphanet Journal of Rare Diseases|September 7, 2018
Eight years after an international workshop on myotonic dystrophy patient registries: case study of a global collaboration for a rare diseaseLibby Wood, Guillaume Bassez, Corinne Bleyenheuft, et al.
Pageof 6